MedPath

Effects of expectations, medication and placebo during the Quantified Behavior Test in patients with untreated ADHD.

Conditions
Effects of expectations, medication and placebo on objective and self-rated performance during the Quantified Behavior Test in terms of the ADHD core signs hyperactivity, inattention and impulsivity in patients with untreated ADHD.
Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]
Registration Number
EUCTR2014-005045-53-SE
Lead Sponsor
andstinget Västmanland
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. 18 years old or older.
2. ADHD is diagnosed according to DSM-5 criteria.
3. Qb-score 1.3 or higher on any of the weighted summary parameters QbActivity, QbInAttention or QbImpulsivity on the
QbTest.
4. Patiens are given their written informed consent to participate in the study.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 40
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

1. Affected by alcohol or drugs during the last month.
2. Untreated severe comorbid psychiatric or somatic illness.
3. Bloodpressure 150/95 or higher.
4. irregular pulse, or pulse 100 or higher.
5. No counter indications according to the Medikinet pill.
6. Concurrent clinical diagnosis that significantly could affect test performance.
7. Concurrent prescription of medicines for ADHD or medicines that significantliy could affect test performance.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: To examine the effects of expectations, medication and placebo on objective and self-rated performance on ADHD core signs during the Quantified Behavior Test.;Secondary Objective: Not applicable.;Primary end point(s): Primary outcom variables are the weighted summary parameters QbActivity, QbInattention and QbImpulsivity on the Qb Test plus.;Timepoint(s) of evaluation of this end point: December 2016
Secondary Outcome Measures
NameTimeMethod
Secondary end point(s): Secondary outcom variables are self-rated scales concerning expected and experienced performance on the Qb Test, help from the pill, and perceived severity on the task.;Timepoint(s) of evaluation of this end point: December 2016
© Copyright 2025. All Rights Reserved by MedPath